GB1570993A - Pharmaceutical tablet formulation - Google Patents

Pharmaceutical tablet formulation Download PDF

Info

Publication number
GB1570993A
GB1570993A GB20984/76A GB2098476A GB1570993A GB 1570993 A GB1570993 A GB 1570993A GB 20984/76 A GB20984/76 A GB 20984/76A GB 2098476 A GB2098476 A GB 2098476A GB 1570993 A GB1570993 A GB 1570993A
Authority
GB
United Kingdom
Prior art keywords
formulation according
active ingredient
weight
tablet
pyran
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB20984/76A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Priority to GB20984/76A priority Critical patent/GB1570993A/en
Priority to FR7714858A priority patent/FR2426460A1/fr
Priority to BE177619A priority patent/BE854690A/xx
Priority to IL52102A priority patent/IL52102A0/xx
Priority to SE7705850A priority patent/SE7705850L/xx
Priority to AU25214/77A priority patent/AU511269B2/en
Priority to ZA00772989A priority patent/ZA772989B/xx
Priority to DK218777A priority patent/DK218777A/da
Priority to NZ184141A priority patent/NZ184141A/xx
Priority to LU77369A priority patent/LU77369A1/xx
Priority to CA278,833A priority patent/CA1105835A/en
Priority to FI771587A priority patent/FI771587A/fi
Priority to JP5712777A priority patent/JPS52143220A/ja
Priority to NO771765A priority patent/NO771765L/no
Priority to NL7705560A priority patent/NL7705560A/xx
Priority to IE2005/80A priority patent/IE45283B1/en
Priority to DE19772722917 priority patent/DE2722917A1/de
Priority to IE1038/77A priority patent/IE45282B1/en
Publication of GB1570993A publication Critical patent/GB1570993A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB20984/76A 1976-05-21 1976-05-21 Pharmaceutical tablet formulation Expired GB1570993A (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
GB20984/76A GB1570993A (en) 1976-05-21 1976-05-21 Pharmaceutical tablet formulation
FR7714858A FR2426460A1 (fr) 1976-05-21 1977-05-16 Composition antiallergique
BE177619A BE854690A (fr) 1976-05-21 1977-05-16 Composition antiallergique
IL52102A IL52102A0 (en) 1976-05-21 1977-05-16 Novel pharmaceutical formulations comprising anti-allergic drugs and in particular chromone-2-carboxylic acids
SE7705850A SE7705850L (sv) 1976-05-21 1977-05-17 Forfarande for framstellning av en farmaceutisk komposition
AU25214/77A AU511269B2 (en) 1976-05-21 1977-05-17 Anti-allergic tablet compositions
ZA00772989A ZA772989B (en) 1976-05-21 1977-05-18 Non-allergenic tablet formulation of anti-allergic drugs
DK218777A DK218777A (da) 1976-05-21 1977-05-18 Fremgangsmade til fremstilling af en farmaceutisk tabletkomposition indeholdende anti-allergisk legemiddel
NZ184141A NZ184141A (en) 1976-05-21 1977-05-18 Pharmaceutical tablet formulation containing anti-allergic drug
LU77369A LU77369A1 (US20100268047A1-20101021-C00003.png) 1976-05-21 1977-05-18
CA278,833A CA1105835A (en) 1976-05-21 1977-05-19 Pharmaceutical tablet comprising anti-allergic drug
FI771587A FI771587A (US20100268047A1-20101021-C00003.png) 1976-05-21 1977-05-19
JP5712777A JPS52143220A (en) 1976-05-21 1977-05-19 Tablet type pharmaceutical composition
NO771765A NO771765L (no) 1976-05-21 1977-05-20 Fremgangsm}te til fremstilling av et nytt farmas¦ytisk preparat
NL7705560A NL7705560A (nl) 1976-05-21 1977-05-20 Farmaceutisch preparaat.
IE2005/80A IE45283B1 (en) 1976-05-21 1977-05-20 Pharmaceutical formulation
DE19772722917 DE2722917A1 (de) 1976-05-21 1977-05-20 Pharmazeutische zusammensetzung
IE1038/77A IE45282B1 (en) 1976-05-21 1977-05-20 Pharmaceutical tablet formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB20984/76A GB1570993A (en) 1976-05-21 1976-05-21 Pharmaceutical tablet formulation

Publications (1)

Publication Number Publication Date
GB1570993A true GB1570993A (en) 1980-07-09

Family

ID=10155196

Family Applications (1)

Application Number Title Priority Date Filing Date
GB20984/76A Expired GB1570993A (en) 1976-05-21 1976-05-21 Pharmaceutical tablet formulation

Country Status (17)

Country Link
JP (1) JPS52143220A (US20100268047A1-20101021-C00003.png)
AU (1) AU511269B2 (US20100268047A1-20101021-C00003.png)
BE (1) BE854690A (US20100268047A1-20101021-C00003.png)
CA (1) CA1105835A (US20100268047A1-20101021-C00003.png)
DE (1) DE2722917A1 (US20100268047A1-20101021-C00003.png)
DK (1) DK218777A (US20100268047A1-20101021-C00003.png)
FI (1) FI771587A (US20100268047A1-20101021-C00003.png)
FR (1) FR2426460A1 (US20100268047A1-20101021-C00003.png)
GB (1) GB1570993A (US20100268047A1-20101021-C00003.png)
IE (1) IE45282B1 (US20100268047A1-20101021-C00003.png)
IL (1) IL52102A0 (US20100268047A1-20101021-C00003.png)
LU (1) LU77369A1 (US20100268047A1-20101021-C00003.png)
NL (1) NL7705560A (US20100268047A1-20101021-C00003.png)
NO (1) NO771765L (US20100268047A1-20101021-C00003.png)
NZ (1) NZ184141A (US20100268047A1-20101021-C00003.png)
SE (1) SE7705850L (US20100268047A1-20101021-C00003.png)
ZA (1) ZA772989B (US20100268047A1-20101021-C00003.png)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002087546A2 (en) * 2001-05-01 2002-11-07 Pfizer Products Inc. Method for manufacturing a low dose pharmaceutical composition

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1595220A (en) * 1977-12-23 1981-08-12 Fisons Ltd Tablets containing 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane
US5447728A (en) * 1992-06-15 1995-09-05 Emisphere Technologies, Inc. Desferrioxamine oral delivery system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA753210B (en) * 1974-06-14 1976-04-28 Upjohn Co Novel dosing regimen for intal biologues
IL48360A (en) * 1974-11-09 1978-12-17 Fisons Ltd Pharmaceutical compositions for the treatment of aphthous stomatitis comprising 1,3-bis-(2-carboxychromon-5-yloxy)-2-carboxychromon-5-yloxy)-2-hydroxypropane
HU175915B (en) * 1974-11-30 1980-11-28 Fisons Ltd Process for producing monochromone derivatives

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002087546A2 (en) * 2001-05-01 2002-11-07 Pfizer Products Inc. Method for manufacturing a low dose pharmaceutical composition
WO2002087546A3 (en) * 2001-05-01 2003-02-13 Pfizer Prod Inc Method for manufacturing a low dose pharmaceutical composition
US7037530B2 (en) 2001-05-01 2006-05-02 Pfizer Inc Method for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency
US7176221B2 (en) 2001-05-01 2007-02-13 Pfizer Inc. Low dose pharmaceutical composition having uniform drug distribution and potency

Also Published As

Publication number Publication date
LU77369A1 (US20100268047A1-20101021-C00003.png) 1977-12-13
FI771587A (US20100268047A1-20101021-C00003.png) 1977-11-22
DE2722917A1 (de) 1977-12-01
AU511269B2 (en) 1980-08-07
NZ184141A (en) 1979-06-19
FR2426460A1 (fr) 1979-12-21
IL52102A0 (en) 1977-07-31
IE45282B1 (en) 1982-07-28
BE854690A (fr) 1977-11-16
NL7705560A (nl) 1977-11-23
IE45282L (en) 1977-11-21
AU2521477A (en) 1978-11-23
ZA772989B (en) 1978-04-26
CA1105835A (en) 1981-07-28
NO771765L (no) 1977-11-22
FR2426460B1 (US20100268047A1-20101021-C00003.png) 1983-04-29
DK218777A (da) 1977-11-22
SE7705850L (sv) 1977-11-22
JPS52143220A (en) 1977-11-29

Similar Documents

Publication Publication Date Title
JP3037757B2 (ja) パロキセチン錠およびその製法
US3148124A (en) Method of preparing sustained release pharmaceutical tablets
US4929605A (en) Pharmaceutical composition for piperidinoalkanol derivatives
ATE307569T1 (de) Gelierbare pharmazeutische zusammensetzungen
EP0324725B1 (en) A pharmaceutical composition
US5576346A (en) Process for treating uremic pruritus
KR900011451A (ko) 새로운 의약품 제제
WO2004019937A1 (en) Pharmaceutical composition of metaxalone with enhanced oral bioavailability
GB1570993A (en) Pharmaceutical tablet formulation
AU615950B2 (en) Pharmaceutical composition for piperidinoalkanol derivatives
US4428951A (en) Long acting pharmaceutical composition
JPH069391A (ja) ヒアルロニダーゼ活性阻害剤
US3224940A (en) Antacid compositions and method of using same
JPH10218780A (ja) 肛門直腸疾患および結腸疾患の制御および処置のための新規な薬学組成物およびその製造方法
GB2061111A (en) Long acting pharmaceutical composition
WO1980001242A1 (en) Galenical preparation
GB1570994A (en) Pharmaceutical formulation
IE45283B1 (en) Pharmaceutical formulation
US2224256A (en) Pharmaceutical preparation
EP0818987A1 (en) Composition and process for prevention and treatment of cutaneous immediate hypersensitivity reactions
JPH08325142A (ja) ヨウ化イソプロパミド含有製剤
US5217965A (en) Stabilized solid dosage forms of choline metal carboxymethylcellulose salicylate compositions
RU2154467C2 (ru) СОСТАВ ИНГИБИТОРА 5α-РЕДУКТАЗЫ ДЛЯ ОРАЛЬНОГО ВВЕДЕНИЯ, СПОСОБ ЕГО ПОЛУЧЕНИЯ И ЕГО ИСПОЛЬЗОВАНИЕ
JPH072697A (ja) 呼吸性アレルギーに対する局所的製薬組成物
US3824314A (en) Anti-inflammatory preparations

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee